Challenges and future perspectives of transcatheter tricuspid valve interventions: adopt old strategies or adapt to new opportunities?
Structural heart disease interventions
Tricuspid regurgitation
Tricuspid valve repair
Tricuspid valve replacement
Valvular heart disease
transcatheter tricuspid valve interventions
Journal
European journal of heart failure
ISSN: 1879-0844
Titre abrégé: Eur J Heart Fail
Pays: England
ID NLM: 100887595
Informations de publication
Date de publication:
03 2022
03 2022
Historique:
revised:
02
12
2021
received:
17
07
2021
accepted:
04
12
2021
pubmed:
12
12
2021
medline:
8
4
2022
entrez:
11
12
2021
Statut:
ppublish
Résumé
Tricuspid regurgitation (TR) is a highly prevalent valvular heart disease and is associated with an increased risk of cardiovascular events and death at long-term follow-up. Functional TR accounts for over 90% of TR and is mainly due to annular or right ventricular dilatation. Most often, TR is observed in patients with left-sided valvular heart disease (with or without previous surgical correction) and pulmonary hypertension. Isolated TR is less frequent, though burdened by high surgical mortality. This, together with an incomplete understanding of the disease, has brought to a significant undertreatment in spite of the growing evidence of the impact of severe TR on mortality. Moreover, uncertainties about the appropriate timing for intervention and the predictors of procedural success have contributed to limit TR treatment. Transcatheter tricuspid valve replacement or repair interventions represent novel and less invasive alternatives to surgery and have shown early promising results. The purpose of this review is to provide a complete and updated overview of TR pathology with a special focus on current percutaneous treatment options, future challenges and directions.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
442-454Informations de copyright
© 2021 European Society of Cardiology.
Références
Zack CJ, Fender EA, Chandrashekar P, Reddy YNV, Bennett CE, Stulak JM, et al. National trends and outcomes in isolated tricuspid valve surgery. J Am Coll Cardiol. 2017;70:2953-60.
Alqahtani F, Berzingi CO, Aljohani S, Hijazi M, Al-Hallak A, Alkhouli M. Contemporary trends in the use and outcomes of surgical treatment of tricuspid regurgitation. J Am Heart Assoc. 2017;6:e007597.
Singh JP, Evans JC, Levy D, Larson MG, Freed LA, Fuller DL, et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol. 1999;83:897-902.
Topilsky Y, Maltais S, Medina Inojosa J, Oguz D, Michelena H, Maalouf J, et al. Burden of tricuspid regurgitation in patients diagnosed in the community setting. JACC Cardiovasc Imaging. 2019;12:433-42.
Messika-Zeitoun D, Verta P, Gregson J, Pocock SJ, Boero I, Feldman TE, et al. Impact of tricuspid regurgitation on survival in patients with heart failure: a large electronic health record patient-level database analysis. Eur J Heart Fail. 2020;22:1803-13.
Chorin E, Rozenbaum Z, Topilsky Y, Konigstein M, Ziv-Baran T, Richert E, et al. Tricuspid regurgitation and long-term clinical outcomes. Eur Heart J Cardiovasc Imaging. 2020;21:157-65.
Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, et al.; PARTNER 3 Investigators. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380:1695-705.
Barbanti M, Binder RK, Dvir D, Tan J, Freeman M, Thompson CR, et al. Prevalence and impact of preoperative moderate/severe tricuspid regurgitation on patients undergoing transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2015;85:677-84.
Ohno Y, Attizzani GF, Capodanno D, Cannata S, Dipasqua F, Immé S, et al. Association of tricuspid regurgitation with clinical and echocardiographic outcomes after percutaneous mitral valve repair with the MitraClip System: 30-day and 12-month follow-up from the GRASP Registry. Eur Heart J Cardiovasc Imaging. 2014;15:1246-55.
Pavasini R, Ruggerini S, Grapsa J, Biscaglia S, Tumscitz C, Serenelli M, et al. Role of the tricuspid regurgitation after Mitraclip and transcatheter aortic valve implantation: a systematic review and meta-analysis. Eur Heart J Cardiovasc Imaging. 2018;19:654-9.
Asmarats L, Puri R, Latib A, Navia JL, Rodés-Cabau J. Transcatheter tricuspid valve interventions: landscape, challenges, and future directions. J Am Coll Cardiol. 2018;71:2935-56.
Rodés-Cabau J, Taramasso M, O'Gara PT. Diagnosis and treatment of tricuspid valve disease: current and future perspectives. Lancet. 2016;388:2431-42.
Muraru D, Parati G, Badano LP. The tale of functional tricuspid regurgitation: when atrial fibrillation is the villain. Eur Heart J Cardiovasc Imaging. 2020;21:1079-81.
Muraru D, Guta AC, Ochoa-Jimenez RC, Bartos D, Aruta P, Mihaila S, et al. Functional regurgitation of atrioventricular valves and atrial fibrillation: an elusive pathophysiological link deserving further attention. J Am Soc Echocardiogr. 2020;33:42-53.
Guta AC, Badano LP, Tomaselli M, Mihalcea D, Bartos D, Parati G, et al. The pathophysiological link between right atrial remodeling and functional tricuspid regurgitation in patients with atrial fibrillation: a three-dimensional echocardiography study. J Am Soc Echocardiogr. 2021;34:585-94.e1.
Lee R, Li S, Rankin JS, O'Brien SM, Gammie JS, Peterson ED, et al.; Society of Thoracic Surgeons Adult Cardiac Surgical Database. Fifteen-year outcome trends for valve surgery in North America. Ann Thorac Surg. 2011;91:677-84.
Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, et al. 2020 ACC/AHA Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143:e72-e227.
Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al.; ESC/EACTS Scientific Document Group. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022;43:561-632.
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al.; ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur J Heart Fail. 2022;24:4-131.
Connolly HM, Schaff HV, Abel MD, Rubin J, Askew JW, Li Z, et al. Early and late outcomes of surgical treatment in carcinoid heart disease. J Am Coll Cardiol. 2015;66:2189-96.
Seeburger J, Borger MA, Passage J, Misfeld M, Holzhey D, Noack T, et al. Minimally invasive isolated tricuspid valve surgery. J Heart Valve Dis. 2010;19:189-92.
Bevan PJ, Haydock DA, Kang N. Long-term survival after isolated tricuspid valve replacement. Heart Lung Circ. 2014;23:697-702.
De Meester P, Van De Bruaene A, Voigt JU, Herijgers P, Budts W. Outcome and determinants of prognosis in patients undergoing isolated tricuspid valve surgery: retrospective single center analysis. Int J Cardiol. 2014;175:333-9.
Chikwe J, Itagaki S, Anyanwu A, Adams DH. Impact of concomitant tricuspid annuloplasty on tricuspid regurgitation, right ventricular function, and pulmonary artery hypertension after repair of mitral valve prolapse. J Am Coll Cardiol. 2015;65:1931-8.
Beckmann A, Funkat AK, Lewandowski J, Frie M, Ernst M, Hekmat K, et al. German heart surgery report 2016: the annual updated registry of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg. 2017;65:505-18.
Kim YJ, Kwon DA, Kim HK, Park JS, Hahn S, Kim KH, et al. Determinants of surgical outcome in patients with isolated tricuspid regurgitation. Circulation. 2009;120:1672-8.
Kay JH, Maselli-Campagna G, Tsuji HK. Surgical treatment of tricuspid insufficiency. Ann Surg. 1965;162:53-8.
De Vega NG. Selective, adjustable and permanent annuloplasty. An original technic for the treatment of tricuspid insufficiency. Rev Esp Cardiol. 1972;25:555-6.
Parolari A, Barili F, Pilozzi A, Pacini D. Ring or suture annuloplasty for tricuspid regurgitation? A meta-analysis review. Ann Thorac Surg. 2014;98:2255-63.
Pagnesi M, Montalto C, Mangieri A, Agricola E, Puri R, Chiarito M, et al. Tricuspid annuloplasty versus a conservative approach in patients with functional tricuspid regurgitation undergoing left-sided heart valve surgery: a study-level meta-analysis. Int J Cardiol. 2017;240:138-44.
Tang GH, David TE, Singh SK, Maganti MD, Armstrong S, Borger MA. Tricuspid valve repair with an annuloplasty ring results in improved longterm outcomes. Circulation. 2006;114:I577-81.
Hahn RT, Thomas JD, Khalique OK, Cavalcante JL, Praz F, Zoghbi WA. Imaging assessment of tricuspid regurgitation severity. JACC Cardiovasc Imaging. 2019;12:469-90.
Muraru D, Hahn RT, Soliman OI, Faletra FF, Basso C, Badano LP. 3-Dimensional echocardiography in imaging the tricuspid valve. JACC Cardiovasc Imaging. 2019;12:500-15.
Kitamura M, Kresoja KP, Besler C, Leontyev S, Kiefer P, Rommel KP, et al. Impact of tricuspid valve morphology on clinical outcomes after transcatheter edge-to-edge repair. JACC Cardiovasc Interv. 2021;14:1616-8.
Hahn RT, Zamorano JL. The need for a new tricuspid regurgitation grading scheme. Eur Heart J Cardiovasc Imaging. 2017;18:1342-3.
Topilsky Y, Khanna A, Le Tourneau T, Park S, Michelena H, Suri R, et al. Clinical context and mechanism of functional tricuspid regurgitation in patients with and without pulmonary hypertension. Circ Cardiovasc Imaging. 2012;5:314-23.
Mutlak D, Aronson D, Lessick J, Reisner SA, Dabbah S, Agmon Y. Functional tricuspid regurgitation in patients with pulmonary hypertension: is pulmonary artery pressure the only determinant of regurgitation severity? Chest. 2009;135:115-21.
Lurz P, Orban M, Besler C, Braun D, Schlotter F, Noack T, et al. Clinical characteristics, diagnosis, and risk stratification of pulmonary hypertension in severe tricuspid regurgitation and implications for transcatheter tricuspid valve repair. Eur Heart J. 2020;41:2785-95.
D'Alto M, Naeije R. Transcatheter tricuspid valve repair in patients with pulmonary hypertension. Eur Heart J. 2020;41:2811-2.
Stocker TJ, Hertell H, Orban M, Braun D, Rommel KP, Ruf T, et al. Cardiopulmonary hemodynamic profile predicts mortality after transcatheter tricuspid valve repair in chronic heart failure. JACC Cardiovasc Interv. 2021;14:29-38.
Mehr M, Taramasso M, Besler C, Ruf T, Connelly KA, Weber M, et al. 1-Year outcomes after edge-to-edge valve repair for symptomatic tricuspid regurgitation: results from the TriValve Registry. JACC Cardiovasc Interv. 2019;12:1451-61.
Lurz P, von Bardeleben RS, Weber M, Sitges M, Sorajja P, Hausleiter J, et al.; TRILUMINATE Investigators. Transcatheter edge-to-edge repair for treatment of tricuspid regurgitation. J Am Coll Cardiol. 2021;77:229-39.
Kodali S, Hahn RT, Eleid MF, Kipperman R, Smith R, Scott Lim D, et al.; CLASP TR EFS Investigators. Feasibility study of the transcatheter valve repair system for severe tricuspid regurgitation. J Am Coll Cardiol. 2021;77:345-56.
Nickenig G, Weber M, Schüler R, Hausleiter J, Nabauer M, von Bardeleben RS, et al. Tricuspid valve repair with the Cardioband system: two-year outcomes of the multicentre, prospective TRI-REPAIR study. EuroIntervention. 2021;16:e1264-71.
Lauten A, Figulla HR, Unbehaun A, Fam N, Schofer J, Doenst T, et al. Interventional treatment of severe tricuspid regurgitation: early clinical experience in a multicenter, observational, first-in-man study. Circ Cardiovasc Interv. 2018;11:e006061.
Hahn RT, Kodali S, Fam N, Bapat V, Bartus K, Rodés-Cabau J, et al. Early multinational experience of transcatheter tricuspid valve replacement for treating severe tricuspid regurgitation. JACC Cardiovasc Interv. 2020;13:2482-93.
Fam NP, Braun D, von Bardeleben RS, Nabauer M, Ruf T, Connelly KA, et al. Compassionate use of the PASCAL transcatheter valve repair system for severe tricuspid regurgitation: a multicenter, observational, first-in-human experience. JACC Cardiovasc Interv. 2019;12:2488-95.
Planer D, Beeri R, Danenberg HD. First-in-human transcatheter tricuspid valve repair: 30-day follow-up experience with the mistral device. JACC Cardiovasc Interv. 2020;13:2091-6.
Davidson CJ, Lim DS, Smith RL, Kodali SK, Kipperman RM, Eleid MF, et al.; Cardioband TR EFS Investigators. Early feasibility study of cardioband tricuspid system for functional tricuspid regurgitation: 30-day outcomes. JACC Cardiovasc Interv. 2021;14:41-50.
Reddy VY, Abbo AR, Ruiz CE, Kerner A, Kreidel F, Topilsky Y, et al. First-in-human percutaneous circumferential annuloplasty for secondary tricuspid regurgitation. JACC Case Rep. 2020;2:2176-82.
Lu FL, Ma Y, An Z, Cai CL, Li BL, Song ZG, et al. First-in-man experience of transcatheter tricuspid valve replacement with LuX-valve in high-risk tricuspid regurgitation patients. JACC Cardiovasc Interv. 2020;13:1614-6.
Aoi S, Wiley J, Ho E, Goldberg Y, Chau M, Latib A. Transcatheter tricuspid valve implantation with the cardiovalve system. Future Cardiol. 2021;17:963-9.
Jeganathan R, Armstrong S, Al-Alao B, David T. The risk and outcomes of reoperative tricuspid valve surgery. Ann Thorac Surg. 2013;95:119-24.
Kenny D, Hijazi ZM, Walsh KP. Transcatheter tricuspid valve replacement with the Edwards SAPIEN valve. Catheter Cardiovasc Interv. 2011;78:267-70.
Calvert PA, Himbert D, Brochet E, Radu C, Iung B, Hvass U, et al. Transfemoral implantation of an Edwards SAPIEN valve in a tricuspid bio-prosthesis without fluoroscopic landmarks. EuroIntervention. 2012;7:1336-9.
Hoendermis ES, Douglas YL, van den Heuvel AF. Percutaneous Edwards SAPIEN valve implantation in the tricuspid position: case report and review of literature. EuroIntervention. 2012;8:628-33.
McElhinney DB, Aboulhosn JA, Dvir D, Whisenant B, Zhang Y, Eicken A, et al.; VIVID Registry. Mid-term valve-related outcomes after transcatheter tricuspid valve-in-valve or valve-in-ring replacement. J Am Coll Cardiol. 2019;73:148-57.
Taramasso M, Nietlispach F, Dvir D, Anabitarte P, Moarof I, Webb JG, et al. Transfemoral tricuspid valve-in-valve implantation: snare it to make it simpler! EuroIntervention. 2016;12:402.
Mazitelli D, Bleiziffer S, Noebauer C, Ruge H, Mayr P, Opitz A, et al. Transatrial antegrade approach for double mitral and tricuspid “valve-in-ring” implantation. Ann Thorac Surg. 2015;95:e25-7.
Cabasa AS, Eleid MF, Rihal CS, Villarraga HR, Foley TA. Tricuspid valve replacement: a percutaneous transfemoral valve-in-ring approach. JACC Cardiovasc Interv. 2015;8:1126-8.
Bouleti C, Himbert D, Brochet E, Ou P, Iung B, Nejjari M, et al. Transfemoral tricuspid valve-in-ring implantation using the Edwards SAPIEN XT valve: one-year follow-up. Circ Cardiovasc Interv. 2015;8:e002225.
Sanon S, Cabalka AK, Babaliaros V, Rihal C, Gafoor S, Webb J, et al. Transcatheter tricuspid valve-in-valve and valve-in-ring implantation for degenerated surgical prosthesis. JACC Cardiovasc Interv. 2019;12:1403-12.
Russo G, Gennari M, Gavazzoni M, Pedicino D, Pozzoli A, Taramasso M, et al., Transcatheter mitral valve implantation: current status and future perspectives. Circ Cardiovasc Interv 2021; 14:e010628.
Taramasso M, Benfari G, van der Bijl P, Alessandrini H, Attinger-Toller A, Biasco L, et al. Transcatheter versus medical treatment of patients with symptomatic severe tricuspid regurgitation. J Am Coll Cardiol. 2019;74:2998-3008.
Van Aelst LN, Čelutkienė J, Mebazaa A. Advanced heart failure: look right to prognosticate right! Eur J Heart Fail. 2016;18:573-5.
Taramasso M, Hahn RT, Alessandrini H, Latib A, Attinger-Toller A, Braun D, et al. The International Multicenter TriValve Registry: which patients are undergoing transcatheter tricuspid repair? JACC Cardiovasc Interv. 2017;10:1982-90.
Ruf TF, Hahn RT, Kreidel F, Beiras-Fernandez A, Hell M, Gerdes P, et al. Short-term clinical outcomes of transcatheter tricuspid valve repair with the third-generation MitraClip XTR System. JACC Cardiovasc Interv. 2021;14:1231-40.
Karam N, Mehr M, Taramasso M, Besler C, Ruf T, Connelly KA, et al. Value of echocardiographic right ventricular and pulmonary pressure assessment in predicting transcatheter tricuspid repair outcome. JACC Cardiovasc Interv. 2020;13:1251-61.
Schlotter F, Miura M, Kresoja KP, Alushi B, Alessandrini H, Attinger-Toller A, et al., Outcomes of transcatheter tricuspid valve intervention by right ventricular function: a multicentre propensity-matched analysis. EuroIntervention 2021; 17:e343-52.
Miura M, Alessandrini H, Alkhodair A, Attinger-Toller A, Biasco L, Lurz P, et al. Impact of massive or torrential tricuspid regurgitation in patients undergoing transcatheter tricuspid valve intervention. JACC Cardiovasc Interv. 2020;13:1999-2009.
Schlotter F, Orban M, Rommel KP, Besler C, von Roeder M, Braun D, et al. Aetiology-based clinical scenarios predict outcomes of transcatheter edge-to-edge tricuspid valve repair of functional tricuspid regurgitation. Eur J Heart Fail. 2019;21:1117-25.
Unterhuber M, Kresoja KP, Besler C, Rommel KP, Orban M, von Roeder M, et al. Cardiac output states in patients with severe functional tricuspid regurgitation: impact on treatment success and prognosis. Eur J Heart Fail. 2021;23:1784-94.
Besler C, Unterhuber M, Rommel KP, Unger E, Hartung P, von Roeder M, et al. Nutritional status in tricuspid regurgitation: implications of transcatheter repair. Eur J Heart Fail. 2020;22:1826-36.
Obadia JF, Messika-Zeitoun D, Leurent G, Iung B, Bonnet G, Piriou N, et al. Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med. 2018;379:2297-306.
Stone GW, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM, et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med. 2018;379:2307-18.
Grayburn PA, Sannino A, Packer M. Proportionate and disproportionate functional mitral regurgitation: a new conceptual framework that reconciles the results of the MITRA-FR and COAPT Trials. JACC Cardiovasc Imaging. 2019;12:353-62.
Dreyfus GD, Essayagh B. Right-heart catheterization of severe functional tricuspid regurgitation: a step forward in reducing its pervasive undertreatment? JACC Cardiovasc Interv. 2021;14:39-40.
Chhatriwalla AK, Vemulapalli S, Szerlip M, Kodali S, Hahn RT, Saxon JT, et al. Operator experience and outcomes of transcatheter mitral valve repair in the United States. J Am Coll Cardiol. 2019;74:2955-65.
Gavazzoni M, Taramasso M, Zuber M, Russo G, Pozzoli A, Miura M, et al. Conceiving MitraClip as a tool: percutaneous edge-to-edge repair in complex mitral valve anatomies. Eur Heart J Cardiovasc Imaging. 2020;21:1059-67.
Taramasso M, Zuber M, Kuwata S, Nietlispach F, Maisano F. Clipping of the tricuspid valve: proposal of a "Rosetta Stone" nomenclature for procedural 3D transoesophageal guidance. EuroIntervention. 2017;12:e1825-7.
Taramasso M, Pozzoli A, Basso C, Thiene G, Denti P, Kuwata S, et al. Compare and contrast tricuspid and mitral valve anatomy: interventional perspectives for transcatheter tricuspid valve therapies. EuroIntervention. 2018;13:1889-98.
Oakley L, Yoon SH, Makar M, Yung A, Patel D, Sekhon N, et al. Left-sided venous access: a technique to simplify and improve success of tricuspid valve clip repair. JACC Cardiovasc Interv. 2021;14:581-2.
Maisano F, Russo G, Tagliari AP, Gavazzoni M, Taramasso M. Left femoral vein access for transcatheter mitral valve interventions in unfavorable interatrial septal anatomy. Catheter Cardiovasc Interv 2021; 98:E971-6.
Russo G, Taramasso M, Maisano F. Transseptal puncture: procedural guidance, challenging situations and management of complications. EuroIntervention. 2021;17:720-7.
Hahn RT, Nabauer M, Zuber M, Nazif TM, Hausleiter J, Taramasso M, et al. Intraprocedural imaging of transcatheter tricuspid valve interventions. JACC Cardiovasc Imaging. 2019;12:532-53.
Khalique OK, Hahn RT. Percutaneous mitral valve repair: multi-modality cardiac imaging for patient selection and intra-procedural guidance. Front Cardiovasc Med. 2019;6:142.
Walmsley J, Squara P, Wolfhard U, Cornelussen R, Lumens J. Impact of abrupt versus gradual correction of mitral and tricuspid regurgitation: a modelling study. EuroIntervention. 2019;15:902-11.
Pagnesi M, Moroni F, Beneduce A, Giannini F, Colombo A, Weisz G, et al. Thrombotic risk and antithrombotic strategies after transcatheter mitral valve replacement. JACC Cardiovasc Interv. 2019;12:2388-401.
Goldberg YH, Ho E, Chau M, Latib A. Update on transcatheter tricuspid valve replacement therapies. Front Cardiovasc Med. 2021;8:619558.